High frequency of germline variants in CFTR identified in PDAC patients enrolled in an expanded panel multi-gene panel testing program

被引：0
|
作者：
Hendifar, Andrew [1 ]
Hitchins, Megan [1 ]
Lauzon, Marie [1 ]
Hatchell, Kathryn E. [2 ]
Heald, Brandie [2 ]
Pandol, Stephen [3 ]
Naren, Anjaparavanda P. [3 ]
Osipov, Arsen [1 ]
机构：
[1] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Ctr, Los Angeles, CA 90048 USA
[2] Invitae, San Francisco, CA USA
[3] Cedars Sinai Med, Los Angeles, CA USA
来源：
HPB | 2024年 / 26卷 / 08期
关键词：
RISK; MUTATIONS; CANCER; GENES;
D O I：
10.1016/j.hpb.2024.05.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1082 / 1085
页数：4
相关论文
共 48 条
  • [31] Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India
    Mannan, Ashraf U.
    Singh, Jaya
    Lakshmikeshava, Ravikiran
    Thota, Nishita
    Singh, Suhasini
    Sowmya, T. S.
    Mishra, Avshesh
    Sinha, Aditi
    Deshwal, Shivani
    Soni, Megha R.
    Chandrasekar, Anbukayalvizhi
    Ramesh, Bhargavi
    Ramamurthy, Bharat
    Padhi, Shila
    Manek, Payal
    Ramalingam, Ravi
    Kapoor, Suman
    Ghosh, Mithua
    Sankaran, Satish
    Ghosh, Arunabha
    Veeramachaneni, Vamsi
    Ramamoorthy, Preveen
    Hariharan, Ramesh
    Subramanian, Kalyanasundaram
    JOURNAL OF HUMAN GENETICS, 2016, 61 (06) : 515 - 522
  • [32] Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening
    Frey, Melissa K.
    Kim, Sarah H.
    Bassett, Rebecca Yee
    Martineau, Jessica
    Dalton, Emily
    Chern, Jing-Yi
    Blank, Stephanie V.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (02) : 211 - 215
  • [33] Multi-Gene Panel Testing for Hereditary Cancer Predisposition Among Patients Sixty-Five Years and Above Diagnosed With Breast Cancer
    Abdel-Razeq, Hikmat
    Tamimi, Faris
    Sharaf, Baha
    Nielsen, Sarah M.
    Heald, Brandie
    Hatchell, Kathryn E.
    Esplin, Edward D.
    Hani, Hira Bani
    Al-Azzam, Khansa
    Alkyam, Mais
    Mustafa, Rawan
    Al-Atary, Areej
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (05) : 777 - 783
  • [34] Evaluating the utility of multi-gene, multi-disease population-based panel testing accounting for uncertainty in penetrance estimates
    Liang, Jane W.
    Christensen, Kurt D.
    Green, Robert C.
    Kraft, Peter
    NPJ GENOMIC MEDICINE, 2024, 9 (01)
  • [35] Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer
    Coughlin, Sarah E.
    Heald, Brandie
    Clark, Dana Farengo
    Nielsen, Sarah M.
    Hatchell, Kathryn E.
    Esplin, Edward D.
    Katona, Bryson W.
    JCO PRECISION ONCOLOGY, 2022, 6
  • [36] Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients
    Tsaousis, Georgios N.
    Papadopoulou, Eirini
    Agiannitopoulos, Konstantinos
    Pepe, Georgia
    Tsoulos, Nikolaos
    Boukovinas, Ioannis
    Floros, Theofanis
    Iosifidou, Rodoniki
    Katopodi, Ourania
    Koumarianou, Anna
    Markopoulos, Christos
    Papazisis, Konstantinos
    Venizelos, Vasileios
    Kapsimalis, Achilleas
    Xepapadakis, Grigorios
    Psyrri, Amanda
    Banu, Eugeniu
    Eniu, Dan Tudor
    Blidaru, Alexandru
    Stanculeanu, Dana Lucia
    Ungureanu, Andrei
    Ozmen, Vahit
    Tansan, Sualp
    Tekinel, Mehmet
    Yalcin, Suayib
    Nasioulas, George
    CANCER GENOMICS & PROTEOMICS, 2022, 19 (01) : 60 - 78
  • [37] Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability
    Antoniadi, Thalia
    Buxton, Chris
    Dennis, Gemma
    Forrester, Natalie
    Smith, Debbie
    Lunt, Peter
    Burton-Jones, Sarah
    BMC MEDICAL GENETICS, 2015, 16
  • [38] Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing
    Mooney, Ryan
    Espinel, Whitney
    Elrick, Ashley
    Kehoe, Kelsey
    Kohlmann, Wendy
    Kaphingst, Kimberly A.
    JOURNAL OF GENETIC COUNSELING, 2022, 31 (02) : 470 - 478
  • [39] Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond BRCA1/BRCA2
    Barbosa, Ana
    Pinto, Pedro
    Peixoto, Ana
    Guerra, Joana
    Pinto, Carla
    Santos, Catarina
    Pinheiro, Manuela
    Escudeiro, Carla
    Bartosch, Carla
    Silva, Joao
    Teixeira, Manuel R.
    CANCERS, 2020, 12 (10) : 1 - 16
  • [40] Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
    Bono, M.
    Fanale, D.
    Incorvaia, L.
    Cancelliere, D.
    Fiorino, A.
    Calo, V.
    Dimino, A.
    Filorizzo, C.
    Corsini, L. R.
    Brando, C.
    Madonia, G.
    Cucinella, A.
    Scalia, R.
    Barraco, N.
    Guadagni, F.
    Pedone, E.
    Badalamenti, G.
    Russo, A.
    Bazan, V.
    ESMO OPEN, 2021, 6 (04)
12345